BRPI0810592A2 - Fator viii recombinante com a manose removida para tratamento de pacientes com hemofilia a - Google Patents

Fator viii recombinante com a manose removida para tratamento de pacientes com hemofilia a

Info

Publication number
BRPI0810592A2
BRPI0810592A2 BRPI0810592-8A2A BRPI0810592A BRPI0810592A2 BR PI0810592 A2 BRPI0810592 A2 BR PI0810592A2 BR PI0810592 A BRPI0810592 A BR PI0810592A BR PI0810592 A2 BRPI0810592 A2 BR PI0810592A2
Authority
BR
Brazil
Prior art keywords
mannosis
treatment
factor viii
hemophilia patients
viii recombinant
Prior art date
Application number
BRPI0810592-8A2A
Other languages
English (en)
Inventor
Chtourou Abdessatar
Lacroix-Desmazes Sami
Dasgupta Sebastien
Bayry Suryasarathi
Srinivas Kaveri Jagadeesh
Original Assignee
Lfb Biotechnologies
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lfb Biotechnologies, Inst Nat Sante Rech Med filed Critical Lfb Biotechnologies
Publication of BRPI0810592A2 publication Critical patent/BRPI0810592A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BRPI0810592-8A2A 2007-04-20 2008-04-21 Fator viii recombinante com a manose removida para tratamento de pacientes com hemofilia a BRPI0810592A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07290495A EP1985631A1 (en) 2007-04-20 2007-04-20 Demannosylated recombinant factor VIII for the treatment of patients with hemophiila A
PCT/IB2008/001417 WO2008129422A1 (en) 2007-04-20 2008-04-21 Demannosylated recombinant factor vii for the treatment of patients with haemophilia a

Publications (1)

Publication Number Publication Date
BRPI0810592A2 true BRPI0810592A2 (pt) 2014-10-21

Family

ID=38515425

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0810592-8A2A BRPI0810592A2 (pt) 2007-04-20 2008-04-21 Fator viii recombinante com a manose removida para tratamento de pacientes com hemofilia a

Country Status (15)

Country Link
US (1) US8802620B2 (pt)
EP (2) EP1985631A1 (pt)
JP (1) JP2010524453A (pt)
KR (1) KR20100017142A (pt)
CN (1) CN101970481A (pt)
AR (1) AR066132A1 (pt)
AT (1) ATE530575T1 (pt)
AU (1) AU2008240663A1 (pt)
BR (1) BRPI0810592A2 (pt)
CA (1) CA2684834A1 (pt)
DK (1) DK2150561T3 (pt)
ES (1) ES2376022T3 (pt)
PL (1) PL2150561T3 (pt)
TW (1) TW200914608A (pt)
WO (1) WO2008129422A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110112022A1 (en) * 2008-06-25 2011-05-12 Bayer Healthcare Llc Factor VIII Muteins with Reduced Immonugenicity
FR2933496B1 (fr) * 2008-07-02 2012-10-05 Lfb Biotechnologies Procede de mesure du taux de facteur vii active dans un echantillon
EP3008084A2 (en) * 2013-06-12 2016-04-20 Novo Nordisk A/S Compounds suitable for treatment of haemophilia
EA201690817A1 (ru) 2013-10-22 2016-08-31 Дбв Текнолоджиз Способ лечения гемофилии индукцией толерантности к факторам крови
EP3114138B1 (en) 2014-03-05 2021-11-17 Pfizer Inc. Improved muteins of clotting factor viii
EP3253786A4 (en) * 2015-02-06 2018-10-17 The University of North Carolina at Chapel Hill Optimized human clotting factor viii gene expression cassettes and their use
BR112018008519A2 (pt) * 2015-10-28 2018-11-06 Sangamo Therapeutics Inc construtos específicos de fígado, cassetes de expressão de fator viii e métodos de uso dos mesmos
US11046749B2 (en) 2016-06-24 2021-06-29 Mogam Institute For Biomedical Research Chimera protein comprising FVIII and vWF factors, and use thereof
US11306329B2 (en) * 2018-02-19 2022-04-19 City Of Hope Adeno-associated virus compositions for restoring F8 gene function and methods of use thereof
CN112575034B (zh) * 2019-09-29 2023-04-25 济南赛尔生物科技股份有限公司 一种治疗a型血友病的产品及应用
CN113248594B (zh) * 2021-04-26 2022-08-30 北京美康基免生物科技有限公司 一种重组凝血因子viii及其应用
US20240254197A1 (en) * 2021-11-25 2024-08-01 Sichuan Real&Best Biotech Co., Ltd. Engineered Human FVIII with Enhanced Secretion Ability and Clotting Activity

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965199A (en) * 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
US6060447A (en) * 1987-05-19 2000-05-09 Chiron Corporation Protein complexes having Factor VIII:C activity and production thereof
US6759216B1 (en) * 1998-11-06 2004-07-06 Emory University Glycosylated, low antigenicity low immunogenicity factor VIII
DK1129186T4 (da) * 1998-11-10 2017-02-06 Stichting Sanquin Bloedvoorziening Et faktor VIII-polypeptid med faktor VIII:C-aktivitet
WO2002096454A1 (en) * 2001-05-31 2002-12-05 D. Collen Research Foundation Vzw Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools
EP1682106A4 (en) * 2003-10-30 2008-06-11 Univ Emory MODIFIED FVIII FACTOR WITH REDUCED IMMUNOGENICITY THROUGH MUTAGENESIS OF A2 AND C2 EPITOPES
US7211559B2 (en) * 2003-10-31 2007-05-01 University Of Maryland, Baltimore Factor VIII compositions and methods

Also Published As

Publication number Publication date
ATE530575T1 (de) 2011-11-15
AU2008240663A1 (en) 2008-10-30
WO2008129422A1 (en) 2008-10-30
US20100197578A1 (en) 2010-08-05
DK2150561T3 (da) 2011-12-19
EP2150561B1 (en) 2011-10-26
TW200914608A (en) 2009-04-01
KR20100017142A (ko) 2010-02-16
ES2376022T3 (es) 2012-03-08
AR066132A1 (es) 2009-07-22
JP2010524453A (ja) 2010-07-22
EP2150561A1 (en) 2010-02-10
PL2150561T3 (pl) 2012-03-30
EP1985631A1 (en) 2008-10-29
WO2008129422A8 (en) 2009-11-19
CN101970481A (zh) 2011-02-09
US8802620B2 (en) 2014-08-12
CA2684834A1 (en) 2008-10-30

Similar Documents

Publication Publication Date Title
BRPI0810592A2 (pt) Fator viii recombinante com a manose removida para tratamento de pacientes com hemofilia a
DE502007004174D1 (de) Markerkomposit für medizinische Implantate
BR112012004546A2 (pt) "terapêutica por proteínas ligantes dll4-ligantes"
BRPI1007675A2 (pt) "dispositivo para inalação de insumos medicinais"
BRPI1012116A2 (pt) composição farmacêutica para o tratamento de doenças cardíacas
BRPI1013015A2 (pt) "osteosíntese com nanoprata"
BRPI0817096A2 (pt) análogos de tiazolidinodiona para o tratamento de hipertensão
DE602007004789D1 (de) Manipulator zur medizinischen Verwendung
SMAP200900085A (it) 3-imidazolil-indoli per il trattamento di malattieproliferative
CO6910184A2 (es) Nuevos compuestos para tratamiento de enfermedades asociadas con proteinas amiloides o tipo amiloide
DK2319433T3 (da) Orthopædkirurgisk instrument
BRPI0816784A2 (pt) Fatores neuro-endócrinos para o tratamento de doenças degenerativas
DK2018206T3 (da) Bandage til medicinsk anvendelse
CR10245A (es) "nuevas combinaciones terapéuticas para el tratamiento de la depresión"
DK2170432T3 (da) Fleksibel medicinsk kanyle
ATE530175T1 (de) Therapeutische kombination für schmerzhafte medizinische zustände
BRPI0817964A2 (pt) Implante cirúrgico
FI20090227A0 (fi) Hammashoidossa käytettävä käsi-instrumentti
DK2056842T3 (da) Modificeret galactosylceramid til behandling af cancerøse sygdomme
EP2182978A4 (en) TISSUE KALLIKREIN FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID PROTEIN
BRPI0906578A2 (pt) Adesivos médicos para a cirurgia
HK1148684A1 (en) Treatment of prion protein related diseases
DK2445543T3 (da) Knogleerstatnings-materiale
BRPI1009448A2 (pt) combinações farmacêuticas compreendendo edea119/bay 869766 para o tratamento de cânceres específicos
SMT201600041B (it) Agenti terapeutici 713

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]